Switch theme
Sign up to access all valuation multiples
PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms, and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.
1970
4.5K+
Last FY Revenue $838M
Last FY EBITDA $142M
$491M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Tempo Scan Pacific achieved revenue of $838M and an EBITDA of $142M.
Tempo Scan Pacific expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Tempo Scan Pacific valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $838M | XXX | XXX | XXX |
| Gross Profit | XXX | $318M | XXX | XXX | XXX |
| Gross Margin | XXX | 38% | XXX | XXX | XXX |
| EBITDA | XXX | $142M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 17% | XXX | XXX | XXX |
| EBIT | XXX | $111M | XXX | XXX | XXX |
| EBIT Margin | XXX | 13% | XXX | XXX | XXX |
| Net Profit | XXX | $88.8M | XXX | XXX | XXX |
| Net Margin | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Tempo Scan Pacific's stock price is IDR 2600 (or $0).
Tempo Scan Pacific has current market cap of IDR 11.73T (or $719M), and EV of IDR 8.00T (or $491M).
See Tempo Scan Pacific trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $491M | $719M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Tempo Scan Pacific has market cap of $719M and EV of $491M.
Tempo Scan Pacific's trades at 0.6x EV/Revenue multiple, and 3.5x EV/EBITDA.
Equity research analysts estimate Tempo Scan Pacific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Tempo Scan Pacific's P/E ratio is not available.
See valuation multiples for Tempo Scan Pacific and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $719M | XXX | $719M | XXX | XXX | XXX |
| EV (current) | $491M | XXX | $491M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 3.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 4.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 8.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 6.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTempo Scan Pacific's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $46K for the same period.
Tempo Scan Pacific's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Tempo Scan Pacific's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Tempo Scan Pacific and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $46K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Tempo Scan Pacific acquired XXX companies to date.
Last acquisition by Tempo Scan Pacific was XXXXXXXX, XXXXX XXXXX XXXXXX . Tempo Scan Pacific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Tempo Scan Pacific founded? | Tempo Scan Pacific was founded in 1970. |
| Where is Tempo Scan Pacific headquartered? | Tempo Scan Pacific is headquartered in Indonesia. |
| How many employees does Tempo Scan Pacific have? | As of today, Tempo Scan Pacific has 4.5K+ employees. |
| Is Tempo Scan Pacific publicy listed? | Yes, Tempo Scan Pacific is a public company listed on IDX. |
| What is the stock symbol of Tempo Scan Pacific? | Tempo Scan Pacific trades under TSPC ticker. |
| When did Tempo Scan Pacific go public? | Tempo Scan Pacific went public in 1994. |
| Who are competitors of Tempo Scan Pacific? | Similar companies to Tempo Scan Pacific include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Tempo Scan Pacific? | Tempo Scan Pacific's current market cap is $719M |
| Is Tempo Scan Pacific profitable? | Yes, Tempo Scan Pacific is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
